Literature DB >> 15984408

Roles for NF-kappaB and c-Fos in osteoclasts.

Brendan F Boyce1, Teruhito Yamashita, Zhenqiang Yao, Qian Zhang, Fang Li, Lianping Xing.   

Abstract

NF-kappaB and c-Fos are transcription factors that are activated in immune cells and in most other cell types following stimulation by a variety of factors, including cytokines, growth factors, and hormones. They regulate the expression of a large number of genes, and both are activated in osteoclast precursors after RANKL, IL-1, or TNF bind to their respective receptors. However, of these cytokines, only RANKL is required for the induction of osteoclast formation in vivo. Nevertheless, it is likely that IL-1, TNF, and other cytokines participate in the upregulation of osteoclast formation seen in a variety of conditions that affect the skeleton in which cytokine production is increased, including estrogen deficiency and inflammatory bone diseases. In this review, the RANKL/ OPG/RANK system and roles for NF-kappaB and c-Fos in osteoclasts are reviewed along with our current understanding of how this system may be disrupted in common bone diseases, such as postmenopausal osteoporosis, inflammatory arthritis, and Paget's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15984408     DOI: 10.1007/BF03026317

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  58 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

Review 4.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

6.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.

Authors:  Koichi Matsuo; Deborah L Galson; Chen Zhao; Lan Peng; Catherine Laplace; Kent Z Q Wang; Marcus A Bachler; Hitoshi Amano; Hiroyuki Aburatani; Hiromichi Ishikawa; Erwin F Wagner
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

8.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Authors:  Dennis M Black; Susan L Greenspan; Kristine E Ensrud; Lisa Palermo; Joan A McGowan; Thomas F Lang; Patrick Garnero; Mary L Bouxsein; John P Bilezikian; Clifford J Rosen
Journal:  N Engl J Med       Date:  2003-09-20       Impact factor: 91.245

9.  Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.

Authors:  L C Hofbauer; C R Dunstan; T C Spelsberg; B L Riggs; S Khosla
Journal:  Biochem Biophys Res Commun       Date:  1998-09-29       Impact factor: 3.575

10.  Bone and haematopoietic defects in mice lacking c-fos.

Authors:  Z Q Wang; C Ovitt; A E Grigoriadis; U Möhle-Steinlein; U Rüther; E F Wagner
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

View more
  27 in total

Review 1.  Nothing but skin and bone.

Authors:  F Patrick Ross; Angela M Christiano
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

2.  VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.

Authors:  Qian Zhang; Ruolin Guo; Yan Lu; Lan Zhao; Quan Zhou; Edward M Schwarz; Jing Huang; Di Chen; Zheng-Gen Jin; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

3.  Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis.

Authors:  Christina D Swanson; Elliot H Akama-Garren; Emily A Stein; Jacob D Petralia; Pedro J Ruiz; Abdolhossein Edalati; Tamsin M Lindstrom; William H Robinson
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

4.  2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes.

Authors:  W F Chiou; J F Liao; C Y Huang; C C Chen
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

5.  Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival.

Authors:  Danielle M Lapierre; Natsuko Tanabe; Alexey Pereverzev; Martha Spencer; Ryan P P Shugg; S Jeffrey Dixon; Stephen M Sims
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

6.  PAMM: a redox regulatory protein that modulates osteoclast differentiation.

Authors:  Yan Xu; Leslie R Morse; Raquel Assed Bezerra da Silva; Paul R Odgren; Hajime Sasaki; Philip Stashenko; Ricardo A Battaglino
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

7.  Polymethylmethacrylate particles stimulate bone resorption of mature osteoclasts in vitro.

Authors:  Hao Zhang; Benjamin F Ricciardi; Xu Yang; Yuexian Shi; Nancy P Camacho; Mathias G Bostrom
Journal:  Acta Orthop       Date:  2008-04       Impact factor: 3.717

8.  Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.

Authors:  Mandeep S Virk; Frank A Petrigliano; Nancy Q Liu; Arion F Chatziioannou; David Stout; Christine O Kang; William C Dougall; Jay R Lieberman
Journal:  Bone       Date:  2008-09-26       Impact factor: 4.398

Review 9.  Inflammation and epigenetic regulation in osteoarthritis.

Authors:  Jie Shen; Yousef Abu-Amer; Regis J O'Keefe; Audrey McAlinden
Journal:  Connect Tissue Res       Date:  2016-07-07       Impact factor: 3.417

10.  Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Chunlin Qin; Edward M Schwarz; Brendan F Boyce
Journal:  J Biol Chem       Date:  2008-02-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.